Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations - PubMed (original) (raw)

Figure 2.

Signaling pathways that mediate the paracrine effects of PVAT. Adiponectin (ADIPOQ) has been shown to mediate many of the beneficial effects of PVAT. ADIPOQ is more highly expressed in lean conditions (top) than in obese conditions (bottom). ADIPOQ causes arterial vasodilation by promoting local eNOS activity in 2 ways: stimulation of AKT‐dependent phosphorylation and subsequent increased eNOS coupling, and by increasing BH4 cofactor availability.(2013) ROS byproducts generated by dysfunctional endothelium (4HNE) feedback to activate PPARγ in adjacent PVAT, thereby stimulating transcription of ADIPOQ and other downstream adipogenic genes. ADIPOQ also promotes endothelium‐independent vasodilation by activation of VSMC potassium channels (not shown). ADIPOQ released by healthy PVAT prevents neointimal hyperplasia by suppressing mitosis of VSMCs in an AMPK‐dependent mechanism(2009) (top). Lipids such as palmitic acid methyl ester (PAME) and prostacyclin (PGI2) have also been shown to stimulate endothelium‐independent vasodilation via direct activation of VSMC potassium channels and PGI2 receptor activation (top).(2012),(2011) Finally, in PVAT from lean mice, unknown growth factor signals converge on mTORC2, resulting in Akt activation and inhibition of inflammatory cytokine production by adipocytes; loss of mTORC2 signaling in Rictor‐deficient mice results in increased inflammation and increased vasoconstriction of underlying VSMC (top).(2013) In obesity, these pathways may be compromised, or new pathological mechanisms may emerge (bottom). Obesity stimulates inflammation and macrophage infiltration, which increases local cytokine and ROS production (bottom). The resultant impairment of insulin signaling contributes to a reduction in beneficial adipokine expression (ADIPOQ, PAME, PGI2), uncoupling of eNOS, and increased expression of pathological vasoconstricting factors (angiotensin 2 [AT2], chemerin, and calpastatin).(2013) PVAT from obese patients may also release factors that stimulate mitosis (eg, leptin, PDGF) of VSMCs by overwhelming local beneficial adipokine effects.(2009),(2011) AMPK indicates adenosine monophosphate kinase; BH4, tetrahydrobiopterin; eNOS, endothelial nitric oxide synthetase; 4HNE, 4‐hydroxynonenal; IL‐6, interleukin 6; iNOS, inducible nitric oxide synthetase; mLST8, MTOR associated protein, LST8; mTORC2, mammalian target of rapamycin complex 2; ONOO−, peroxynitrite; PDGF, platelet‐derived growth factor; PI3K/AKT, Phosphoinositide 3‐kinase; PPARγ, peroxisome proliferator–activated receptor gamma; PVAT, perivascular adipose tissue; ROS, reactive oxygen species; TNFα, tumor necrosis factor alpha; VSMC, vascular smooth muscle cell.